Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dyax and MorphoSys have signed an agreement granting MorphoSys a fully paid-up license to a variety of phage display-related patents from Dyax as well as other patents.
Subscribe to our email newsletter
As part of the license agreement, MorphoSys gains the right to sublicense the patents in conjunction with its proprietary technology. The license agreement provides MorphoSys with flexibility for future technology development to further diversify its antibody technology portfolio and improve its offering for therapeutic, diagnostic and research customers.
Financial terms have not been disclosed.